Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Philip Sung-En Wang, Dr.P.H., M.D.

Concepts (353)

Back to Profile

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name	Number of Publications	Most Recent Publication	Publications by All Authors	Concept Score	Why?
Mental Health Services	18	2010	1643	1.470	Why?
Antidepressive Agents	12	2010	2838	1.350	Why?
Mental Disorders	26	2010	6587	1.220	Why?
Depressive Disorder	10	2010	3748	1.100	Why?
Antipsychotic Agents	13	2009	3058	1.080	Why?
Community Mental Health Services	3	2010	386	0.810	Why?
Suicide, Attempted	5	2010	1218	0.790	Why?
National Institute of Mental Health (U.S.)	3	2010	106	0.790	Why?
Health Services Research	9	2010	1834	0.660	Why?
Health Surveys	17	2009	4030	0.660	Why?
Absenteeism	6	2008	250	0.650	Why?
Suicide	4	2010	1475	0.590	Why?
Depression	9	2022	7733	0.580	Why?
Cost Sharing	2	2010	407	0.520	Why?
Mood Disorders	7	2010	1106	0.510	Why?
Health Services Needs and Demand	7	2010	1411	0.490	Why?
Work	2	2006	191	0.490	Why?
Psychotropic Drugs	4	2009	893	0.470	Why?
Clozapine	4	2007	498	0.470	Why?
Health Policy	5	2010	2657	0.450	Why?
Pharmacogenetics	2	2009	676	0.450	Why?
Comorbidity	20	2022	10372	0.410	Why?
Cost-Benefit Analysis	8	2010	5385	0.410	Why?
Disasters	2	2007	510	0.400	Why?
Patient Compliance	5	2005	2680	0.390	Why?
Adolescent Health Services	2	2010	215	0.370	Why?
British Columbia	6	2010	241	0.360	Why?
Antihypertensive Agents	3	2005	2043	0.360	Why?
Drug Prescriptions	7	2006	1636	0.350	Why?
Substance-Related Disorders	7	2010	4250	0.340	Why?
Cost of Illness	4	2009	1852	0.320	Why?
Efficiency	3	2007	462	0.310	Why?
Depressive Disorder, Major	8	2009	4628	0.310	Why?
Employer Health Costs	1	2006	21	0.300	Why?
World Health Organization	3	2009	1317	0.290	Why?
Hip Fractures	2	2005	954	0.280	Why?
Psychotic Disorders	7	2009	3040	0.280	Why?
Drug Therapy	2	2008	497	0.280	Why?
School Health Services	1	2010	375	0.280	Why?
Community-Institutional Relations	1	2007	204	0.270	Why?
United States	38	2010	69693	0.270	Why?
Prevalence	16	2022	15194	0.260	Why?
Medication Systems	1	2005	31	0.260	Why?
Drug Costs	2	2010	1104	0.260	Why?
Task Performance and Analysis	2	2006	780	0.250	Why?
Arrhythmias, Cardiac	2	2007	2267	0.250	Why?
Behavioral Symptoms	1	2006	175	0.250	Why?
Health Care Surveys	4	2007	2451	0.250	Why?
Workplace	2	2008	836	0.250	Why?
Schizophrenia	4	2009	6874	0.250	Why?
Lung Diseases, Obstructive	1	2005	316	0.240	Why?
Child Health Services	1	2010	667	0.240	Why?
Drug Discovery	2	2010	1057	0.240	Why?
Neurosciences	1	2008	347	0.230	Why?
Chronic Disease	7	2022	9144	0.230	Why?
Delivery of Health Care	7	2010	5304	0.230	Why?
Digoxin	1	2004	250	0.220	Why?
Medicare	8	2009	6532	0.220	Why?
Mortality	4	2007	2857	0.220	Why?
Humans	95	2022	742088	0.220	Why?
Commerce	1	2008	591	0.220	Why?
Clergy	1	2003	83	0.210	Why?
Parasympatholytics	1	2002	91	0.210	Why?
Adolescent	30	2010	85649	0.200	Why?
Narcotics	1	2004	343	0.200	Why?
Managed Care Programs	1	2007	949	0.200	Why?
Dopamine Antagonists	1	2002	296	0.200	Why?
Urban Population	1	2010	2018	0.200	Why?
Lipoproteins, HDL	1	2005	637	0.200	Why?
Specialization	1	2006	777	0.200	Why?
Muscarinic Antagonists	1	2002	137	0.190	Why?
Male	59	2010	349538	0.190	Why?
Bipolar Disorder	3	2007	5024	0.190	Why?
Evidence-Based Medicine	3	2010	3611	0.190	Why?
Occupational Health	1	2007	809	0.190	Why?
Cholinergic Antagonists	1	2002	165	0.190	Why?
Insurance Claim Review	2	2004	720	0.190	Why?
Osteoarthritis	2	2006	1034	0.190	Why?
Female	61	2010	379592	0.190	Why?
New Jersey	7	2006	290	0.190	Why?
Fluvoxamine	2	2010	74	0.180	Why?
Psychiatric Status Rating Scales	8	2007	6030	0.180	Why?
Employment	2	2008	1124	0.180	Why?
Gastrointestinal Diseases	2	2006	1167	0.180	Why?
Health Services Accessibility	6	2010	5133	0.180	Why?
Patient Dropouts	3	2009	421	0.180	Why?
Death, Sudden	1	2002	298	0.180	Why?
Logistic Models	10	2007	13403	0.180	Why?
Central Nervous System Diseases	1	2004	518	0.170	Why?
Anti-Arrhythmia Agents	1	2004	790	0.170	Why?
Aged	38	2022	162944	0.170	Why?
Paroxetine	2	2010	182	0.170	Why?
Patient Care Team	2	2010	2527	0.170	Why?
Population Surveillance	2	2007	2616	0.170	Why?
Adult	38	2010	213712	0.170	Why?
Markov Chains	4	2006	969	0.170	Why?
Cross-Sectional Studies	12	2010	24913	0.160	Why?
Clinical Trials as Topic	3	2010	7901	0.160	Why?
Middle Aged	35	2010	213127	0.160	Why?
Louisiana	2	2007	109	0.160	Why?
Medicaid	4	2007	2716	0.150	Why?
Medicine	1	2006	941	0.150	Why?
Hypertension	5	2005	8455	0.150	Why?
Quality of Health Care	3	2010	4369	0.150	Why?
Randomized Controlled Trials as Topic	3	2009	9941	0.150	Why?
Urinary Incontinence	1	2002	494	0.150	Why?
Survivors	1	2007	2286	0.150	Why?
Quality-Adjusted Life Years	4	2009	1679	0.150	Why?
Hypnotics and Sedatives	1	2005	1158	0.150	Why?
Citalopram	2	2010	404	0.150	Why?
Cohort Studies	13	2010	40450	0.140	Why?
Age of Onset	4	2008	3266	0.140	Why?
Cholesterol	1	2005	2895	0.140	Why?
Biomedical Research	2	2010	3306	0.140	Why?
Fluoxetine	2	2010	749	0.140	Why?
Risk Assessment	8	2009	23320	0.140	Why?
Research Support as Topic	2	2010	704	0.140	Why?
Osteoporosis	1	2005	1581	0.140	Why?
Bone Density	2	2005	3469	0.130	Why?
Health Care Costs	1	2009	3203	0.130	Why?
Severity of Illness Index	7	2009	15530	0.130	Why?
Adrenal Cortex Hormones	1	2004	1847	0.130	Why?
Decision Support Systems, Clinical	1	2004	1162	0.130	Why?
Aged, 80 and over	18	2010	57683	0.120	Why?
Health Status	2	2006	4030	0.120	Why?
Cause of Death	4	2010	3571	0.120	Why?
Diagnostic and Statistical Manual of Mental Disorders	6	2007	1953	0.120	Why?
Models, Theoretical	1	2006	3584	0.120	Why?
Anxiety	3	2022	4279	0.120	Why?
Risk	5	2010	9679	0.120	Why?
Patient Acceptance of Health Care	3	2007	3014	0.120	Why?
Occupations	2	2006	517	0.120	Why?
Income	4	2008	1904	0.120	Why?
Complementary Therapies	3	2009	484	0.120	Why?
Family Practice	2	2006	516	0.110	Why?
Proportional Hazards Models	5	2010	12344	0.110	Why?
Mexico	3	2010	688	0.110	Why?
Benzodiazepines	3	2007	1101	0.110	Why?
Sampling Studies	2	2004	623	0.100	Why?
Probability	6	2009	2502	0.100	Why?
Anxiety Disorders	5	2009	2684	0.100	Why?
Age Distribution	2	2008	2900	0.100	Why?
Costs and Cost Analysis	2	2007	1679	0.090	Why?
Treatment Outcome	8	2010	62966	0.090	Why?
Pennsylvania	6	2007	613	0.090	Why?
Diagnosis, Dual (Psychiatry)	3	2007	295	0.090	Why?
Drug Utilization	5	2009	1181	0.090	Why?
Risk Factors	13	2010	72145	0.090	Why?
Drug Utilization Review	2	2007	245	0.090	Why?
Needs Assessment	2	2007	1146	0.090	Why?
Interviews as Topic	2	2008	2536	0.090	Why?
Health Planning Guidelines	1	2010	163	0.090	Why?
Insurance, Pharmaceutical Services	2	2009	336	0.080	Why?
Pharmacoepidemiology	3	2007	323	0.080	Why?
Prescription Fees	1	2010	146	0.080	Why?
Sertraline	1	2010	206	0.080	Why?
Public Health	1	2002	2594	0.080	Why?
Self Care	2	2004	786	0.080	Why?
Dementia	3	2007	2501	0.080	Why?
Diabetes Mellitus	3	2005	5724	0.080	Why?
Utilization Review	1	2010	392	0.080	Why?
Imipramine	1	2008	97	0.080	Why?
Anti-Inflammatory Agents, Non-Steroidal	3	2006	2276	0.080	Why?
Odds Ratio	4	2008	9846	0.080	Why?
Cyclooxygenase 2 Inhibitors	2	2006	320	0.080	Why?
Therapies, Investigational	1	2008	111	0.080	Why?
Dibenzothiazepines	1	2007	104	0.080	Why?
Ambulatory Care	2	2009	2706	0.070	Why?
Southeastern United States	1	2007	95	0.070	Why?
Adrenergic Uptake Inhibitors	1	2008	189	0.070	Why?
Activities of Daily Living	2	2007	2414	0.070	Why?
Prepaid Health Plans	1	2006	10	0.070	Why?
National Health Programs	1	2010	445	0.070	Why?
Mass Screening	3	2007	5238	0.070	Why?
Chi-Square Distribution	2	2003	3510	0.070	Why?
Pharmaceutical Services	1	2007	140	0.070	Why?
Multivariate Analysis	5	2007	12242	0.070	Why?
Health Services Misuse	1	2007	243	0.070	Why?
Allied Health Personnel	1	2007	162	0.070	Why?
Retrospective Studies	9	2022	77098	0.060	Why?
Risperidone	1	2007	383	0.060	Why?
Databases, Factual	3	2010	7716	0.060	Why?
Child	8	2010	77478	0.060	Why?
Drug Evaluation	1	2006	637	0.060	Why?
Hospitals, Psychiatric	1	2006	332	0.060	Why?
Comparative Effectiveness Research	1	2010	681	0.060	Why?
Death Certificates	1	2006	169	0.060	Why?
Self-Injurious Behavior	1	2010	462	0.060	Why?
Health Services for the Aged	1	2007	269	0.060	Why?
Administration, Oral	3	2008	3913	0.060	Why?
Stroke	1	2007	9963	0.060	Why?
Pravastatin	2	2006	395	0.060	Why?
Quinolones	1	2007	366	0.060	Why?
Salaries and Fringe Benefits	1	2006	264	0.060	Why?
Telephone	1	2007	617	0.060	Why?
Remission Induction	1	2009	2384	0.060	Why?
Patient Education as Topic	2	2004	2275	0.060	Why?
Treatment Failure	1	2009	2615	0.060	Why?
Patient Care Management	1	2006	306	0.060	Why?
Public Health Informatics	1	2004	110	0.060	Why?
Psychiatry	2	2006	1695	0.060	Why?
Product Surveillance, Postmarketing	1	2007	430	0.060	Why?
Direct Service Costs	1	2002	62	0.060	Why?
Risk Adjustment	2	2004	594	0.050	Why?
Early Diagnosis	1	2008	1184	0.050	Why?
Secondary Prevention	1	2009	1520	0.050	Why?
Angiotensin II Type 1 Receptor Blockers	1	2005	453	0.050	Why?
Role	1	2003	175	0.050	Why?
Lipoproteins, LDL	1	2005	628	0.050	Why?
Life Change Events	1	2007	937	0.050	Why?
Research Design	2	2009	5979	0.050	Why?
Longitudinal Studies	2	2009	13921	0.050	Why?
Age Factors	5	2009	18355	0.050	Why?
Monitoring, Physiologic	1	2009	1737	0.050	Why?
Disaster Planning	1	2007	549	0.050	Why?
Hypolipidemic Agents	1	2006	604	0.050	Why?
Hospitals, Veterans	1	2004	404	0.050	Why?
Arthritis	2	2004	658	0.050	Why?
Reimbursement Mechanisms	1	2007	670	0.050	Why?
Hyperlipidemias	1	2006	786	0.050	Why?
Geriatric Assessment	1	2009	1369	0.050	Why?
Calibration	1	2003	815	0.050	Why?
Time Factors	4	2009	40054	0.050	Why?
Health Maintenance Organizations	1	2004	642	0.050	Why?
Psychotherapy	2	2007	1644	0.050	Why?
Prolactin	1	2002	669	0.050	Why?
Hospitalization	2	2010	10232	0.050	Why?
Confidence Intervals	2	2006	2970	0.050	Why?
Thiazoles	1	2007	1484	0.050	Why?
Social Class	1	2009	1995	0.050	Why?
Hospital Costs	1	2006	980	0.050	Why?
Marital Status	1	2002	437	0.050	Why?
Quality Assurance, Health Care	2	2010	2211	0.050	Why?
Treatment Refusal	1	2003	416	0.040	Why?
Medical Records Systems, Computerized	1	2006	1204	0.040	Why?
Data Collection	1	2009	3339	0.040	Why?
Anticholesteremic Agents	2	2006	979	0.040	Why?
Efficiency, Organizational	1	2003	695	0.040	Why?
Government Programs	1	2021	275	0.040	Why?
Medical Records	1	2004	1413	0.040	Why?
Referral and Consultation	2	2010	3527	0.040	Why?
Life Expectancy	1	2005	1183	0.040	Why?
Angiotensin-Converting Enzyme Inhibitors	1	2005	1517	0.040	Why?
Alcoholism	1	2009	1904	0.040	Why?
Education	1	2002	543	0.040	Why?
Cross-Over Studies	1	2004	2030	0.040	Why?
Breast Neoplasms	2	2003	20774	0.040	Why?
Tamoxifen	1	2003	980	0.040	Why?
Medication Adherence	1	2009	2055	0.040	Why?
Internal Medicine	1	2005	1009	0.040	Why?
Occupational Exposure	1	2008	1794	0.040	Why?
Canada	3	2010	2061	0.040	Why?
Insurance Coverage	1	2009	1895	0.040	Why?
Poverty	1	2009	2646	0.040	Why?
Sensitivity and Specificity	2	2010	14720	0.040	Why?
Socioeconomic Factors	3	2008	7770	0.040	Why?
Models, Statistical	2	2009	5100	0.040	Why?
Low Back Pain	1	2006	955	0.040	Why?
Case-Control Studies	3	2004	21719	0.040	Why?
Piperazines	1	2007	2488	0.040	Why?
Sulfonamides	1	2006	1932	0.040	Why?
Insurance, Psychiatric	2	2009	69	0.030	Why?
Pyrazoles	1	2006	1970	0.030	Why?
Quality of Life	2	2009	12730	0.030	Why?
Sex Factors	2	2008	10392	0.030	Why?
Decision Support Techniques	1	2005	1952	0.030	Why?
Guideline Adherence	1	2005	2266	0.030	Why?
Interpersonal Relations	1	2002	1423	0.030	Why?
Antineoplastic Agents, Hormonal	1	2003	1509	0.030	Why?
Dose-Response Relationship, Drug	2	2008	10943	0.030	Why?
Nursing Homes	1	2002	1034	0.030	Why?
Insurance, Health	1	2006	2493	0.030	Why?
Linear Models	1	2004	5948	0.030	Why?
Health Expenditures	1	2007	2346	0.030	Why?
Attention	1	2004	2396	0.030	Why?
Diagnosis-Related Groups	2	2007	454	0.030	Why?
Pulmonary Disease, Chronic Obstructive	2	2005	3038	0.030	Why?
Follow-Up Studies	2	2006	39004	0.030	Why?
Pyridines	1	2005	2818	0.030	Why?
Stress, Psychological	1	2008	4229	0.030	Why?
Circadian Rhythm	1	2004	2623	0.030	Why?
Interview, Psychological	2	2008	812	0.030	Why?
Social Support	1	2002	2117	0.030	Why?
International Classification of Diseases	2	2010	865	0.030	Why?
Regression Analysis	3	2007	6452	0.030	Why?
Reproducibility of Results	5	2008	19862	0.030	Why?
Alzheimer Disease	2	2009	7988	0.020	Why?
Ontario	2	2002	381	0.020	Why?
Epidemiologic Studies	2	2006	676	0.020	Why?
Arthritis, Rheumatoid	1	2006	3695	0.020	Why?
Primary Health Care	1	2006	4551	0.020	Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors	1	2005	3239	0.020	Why?
Gastrointestinal Tract	2	2006	814	0.020	Why?
Analgesics, Opioid	1	2006	3667	0.020	Why?
Asthma	2	2005	5955	0.020	Why?
Clinical Coding	1	2010	171	0.020	Why?
Parents	1	2002	3387	0.020	Why?
Cardiovascular Diseases	4	2008	15108	0.020	Why?
Mental Health	1	2022	2997	0.020	Why?
Diclofenac	1	2006	71	0.020	Why?
Naproxen	1	2006	99	0.020	Why?
Organizational Case Studies	1	2007	299	0.020	Why?
Young Adult	5	2010	56350	0.020	Why?
Attitude to Health	2	2007	2051	0.020	Why?
Antidepressive Agents, Tricyclic	1	2007	434	0.020	Why?
Myocardial Infarction	1	2006	11690	0.020	Why?
Ibuprofen	1	2006	235	0.020	Why?
Forecasting	2	2004	2948	0.020	Why?
State Government	1	2007	369	0.020	Why?
Lactones	1	2006	329	0.010	Why?
Sulfones	1	2006	437	0.010	Why?
Data Interpretation, Statistical	2	2004	2714	0.010	Why?
Scotland	1	2002	155	0.010	Why?
Ireland	1	2002	160	0.010	Why?
Insurance Claim Reporting	1	2003	163	0.010	Why?
Respiratory Tract Diseases	1	2008	722	0.010	Why?
Life Tables	1	2002	370	0.010	Why?
Software Design	1	2002	176	0.010	Why?
Combined Modality Therapy	2	2006	8621	0.010	Why?
Heart Murmurs	1	2002	94	0.010	Why?
Demography	1	2007	1650	0.010	Why?
Prostatic Neoplasms	1	2004	11039	0.010	Why?
Developed Countries	1	2004	436	0.010	Why?
Self-Assessment	1	2003	390	0.010	Why?
Pandemics	1	2021	8328	0.010	Why?
Drug Approval	1	2007	740	0.010	Why?
Patient-Centered Care	1	2010	1436	0.010	Why?
Rheumatic Diseases	1	2006	590	0.010	Why?
Antineoplastic Agents	1	2002	13655	0.010	Why?
Health Services	1	2004	758	0.010	Why?
Drug Therapy, Combination	1	2008	6483	0.010	Why?
Netherlands	1	2002	2170	0.010	Why?
Nervous System Diseases	1	2008	1617	0.010	Why?
Multicenter Studies as Topic	1	2002	1661	0.010	Why?
Neoplasms	2	2005	21596	0.010	Why?
Delirium	1	2008	1608	0.010	Why?
Animals	1	2008	168561	0.010	Why?
Medically Uninsured	1	2002	852	0.010	Why?
Postmenopause	1	2005	2461	0.010	Why?
Disability Evaluation	1	2003	1827	0.010	Why?
Myocardial Ischemia	1	2006	2145	0.010	Why?
Prostate-Specific Antigen	1	2004	2458	0.010	Why?
Program Evaluation	1	2003	2485	0.010	Why?
Mastectomy	1	2003	1789	0.010	Why?
Predictive Value of Tests	1	2010	15056	0.010	Why?
Chemotherapy, Adjuvant	1	2003	3471	0.010	Why?
Developing Countries	1	2004	2789	0.010	Why?
Algorithms	1	2010	13853	0.010	Why?
Practice Guidelines as Topic	1	2005	7276	0.010	Why?
Pain	1	2003	4961	0.000	Why?
Obesity	1	2005	12705	0.000	Why?
Infant	1	2002	35070	0.000	Why?
Child, Preschool	1	2002	40955	0.000	Why?

Wang's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (353)

Explore

Co-Authors (31)

Explore

Similar People (60)

Explore

Same Department

Explore